Imuglucerase injection
Products billed under this code include Cerezyme.
Payment limit per 10 UNITS, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Cerezyme.
Payment limit per 10 UNITS, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Cerezyme | Genzyme Corporation | 58468-4663-01 | 40 | $1,728.12 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $43.203 | −$0.123 | 10 UNITS | Imuglucerase injection | v1, posted September 17, 2026 |
| 3Q26 | $43.326 | +$0.501 | 10 UNITS | Imuglucerase injection | v1, posted September 15, 2026 |
| 2Q26 | $42.825 | −$0.407 | 10 UNITS | Imuglucerase injection | v1, posted September 15, 2026 |
| 1Q26 | $43.232 | +$0.041 | 10 UNITS | Imuglucerase injection | v1, posted September 15, 2026 |
| 4Q25 | $43.191 | −$0.10 | 10 UNITS | Imuglucerase injection | v1, posted September 8, 2026 |
| 3Q25 | $43.291 | +$0.15 | 10 UNITS | Imuglucerase injection | v1, posted March 10, 2026 |
| 2Q25 | $43.141 | −$0.24 | 10 UNITS | Imuglucerase injection | v1, posted March 10, 2026 |
| 1Q25 | $43.381 | −$0.234 | 10 UNITS | Imuglucerase injection | v1, posted December 19, 2025 |
| 4Q24 | $43.615 | −$0.122 | 10 UNITS | Imuglucerase injection | v1, posted June 11, 2025 |
| 3Q24 | $43.737 | −$0.205 | 10 UNITS | Imuglucerase injection | v1, posted June 11, 2025 |
| 2Q24 | $43.942 | −$0.081 | 10 UNITS | Imuglucerase injection | v1, posted March 11, 2025 |
| 1Q24 | $44.023 | −$0.118 | 10 UNITS | Imuglucerase injection | v1, posted December 19, 2024 |
| 4Q23 | $44.141 | −$0.109 | 10 UNITS | Imuglucerase injection | v1, posted October 10, 2024 |
| 3Q23 | $44.25 | −$0.076 | 10 UNITS | Imuglucerase injection | v1, posted June 5, 2024 |
| 2Q23 | $44.326 | −$0.071 | 10 UNITS | Imuglucerase injection | v1, posted February 23, 2024 |
| 1Q23 | $44.397 | +$0.121 | 10 UNITS | Imuglucerase injection | v1, posted December 6, 2023 |
| 4Q22 | $44.276 | +$0.125 | 10 UNITS | Imuglucerase injection | v1, posted June 22, 2023 |
| 3Q22 | $44.151 | +$0.274 | 10 UNITS | Imuglucerase injection | v1, posted June 9, 2023 |
| 2Q22 | $43.877 | −$0.088 | 10 UNITS | Imuglucerase injection | v1, posted December 14, 2022 |
| 1Q22 | $43.965 | −$0.084 | 10 UNITS | Imuglucerase injection | v1, posted June 8, 2022 |
| 4Q21 | $44.049 | +$0.092 | 10 UNITS | Imuglucerase injection | v1, posted June 2, 2022 |
| 3Q21 | $43.957 | +$0.522 | 10 UNITS | Imuglucerase injection | v1, posted June 2, 2022 |
| 2Q21 | $43.435 | +$0.055 | 10 UNITS | Imuglucerase injection | v1, posted March 1, 2022 |
| 1Q21 | $43.38 | – | 10 UNITS | Imuglucerase injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.